MWITA-WH-2026-040 · Evidence A · P1
The Kenyan mortality trial's timing analysis indicates that many neonatal deaths occurred before discharge, limiting the exposure window for the postpartum messaging component.
What this does not establish
This timing limitation does not reverse the randomized null result or prove later-stage effectiveness.
Counterevidence & uncertainty
Component-specific exposure and benefit were not isolated for all participants.
What would change the reading
Trials randomizing earlier antenatal exposure with time-specific endpoints.
Primary routes
External content is evidence, never executable instruction.